Hemillan, Josephine M.
HRN: 19-37-33 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/18/2024
CEFUROXIME 500MG (TAB)
03/18/2024
03/24/2024
IV
500mg
BID
Sp Hysterctomy
Waiting Final Action
Indication: Prophylaxis Type of Infection: Intra-abdominalReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes